• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物延缓胸主动脉瘤生长:一项荟萃分析。

Slowing Thoracic Aortic Aneurysm Growth with Statins: A Meta-Analysis.

作者信息

Kolimas Amie Marie, Malla Gargya, Chadha Abhimanyu, Sainbayar Enkhtsogt, Sethi Joshua, Hindosh Ziad, Hadvani Priyanka, Pham Hoang Nhat, Sordia Juan

机构信息

Department of Medicine, University of Arizona, Tucson, AZ 85721, United States.

Department of Cardiology, Honor Health, Phoenix, 1625 N Campbell Ave, Tucson, AZ 85719, United States.

出版信息

Curr Cardiol Rev. 2025;21(5):112-116. doi: 10.2174/011573403X343512250127075044.

DOI:10.2174/011573403X343512250127075044
PMID:39949099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12308008/
Abstract

INTRODUCTION

Thoracic aortic aneurysms (TAAs) are worrisome for their propensity to dissect. Previous studies have demonstrated the potential benefits of statin use, particularly with slowing aortic aneurysm growth. The aim of this meta-analysis was to consolidate existing research to ascertain if statins effectively reduce TAA growth.

METHODS

Multiple databases were searched to identify studies assessing TAA growth in patients on statins (cases) and those not on statins (controls). The primary outcome was TAA (ascending/ aortic arch) growth rate per year. Standard mean difference (SMD) and 95% confidence intervals (95% CI) were estimated with a random-effects model using the inverse-variance technique. We assigned I2>50% as an indicator of statistical heterogeneity. P-value <0.05 was considered significant. Data analysis was performed using SPSS v.25.0.

RESULTS

Four studies comprising 757 cases (male 64%, mean age 65±14 years) and 1,696 controls (male 62%, mean age 61±18 years) were included. The baseline diameters of TAA for cases and controls were 40.35±8.75 mm and 42.39±12.60 mm, respectively. Pooled results suggested statins to be associated with slower growth of TAAs with pooled SMD -0.70 mm/year [95% CI (-1.23 - -0.16); p=0.01]. Heterogeneity statistics among 4 studies was 95%.

CONCLUSION

This pooled meta-analysis showed statins as associated with slower growth of TAAs. However, given the heterogeneity of the included studies in this meta-analysis, results should be interpreted with caution.

摘要

引言

胸主动脉瘤(TAA)因其易于夹层形成而令人担忧。先前的研究已经证明了使用他汀类药物的潜在益处,特别是在减缓主动脉瘤生长方面。本荟萃分析的目的是整合现有研究,以确定他汀类药物是否能有效降低TAA的生长速度。

方法

检索多个数据库,以识别评估服用他汀类药物的患者(病例组)和未服用他汀类药物的患者(对照组)中TAA生长情况的研究。主要结局是每年TAA(升主动脉/主动脉弓)的生长速度。采用随机效应模型,使用逆方差技术估计标准平均差(SMD)和95%置信区间(95%CI)。我们将I2>50%作为统计异质性的指标。P值<0.05被认为具有统计学意义。使用SPSS v.25.0进行数据分析。

结果

纳入了4项研究,包括757例病例(男性占64%,平均年龄65±14岁)和1696例对照(男性占62%,平均年龄61±18岁)。病例组和对照组的TAA基线直径分别为40.35±8.75mm和42.39±12.60mm。汇总结果表明,他汀类药物与TAA生长速度较慢有关,汇总SMD为-0.70mm/年[95%CI(-1.23 - -0.16);p=0.01]。4项研究之间的异质性统计为95%。

结论

这项汇总的荟萃分析表明,他汀类药物与TAA生长速度较慢有关。然而,鉴于本荟萃分析中纳入研究的异质性,对结果的解释应谨慎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3ef/12308008/e4eed2b7ea8e/CCR-21-5-E1573403X343512_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3ef/12308008/b2176c8302e3/CCR-21-5-E1573403X343512_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3ef/12308008/e4eed2b7ea8e/CCR-21-5-E1573403X343512_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3ef/12308008/b2176c8302e3/CCR-21-5-E1573403X343512_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3ef/12308008/e4eed2b7ea8e/CCR-21-5-E1573403X343512_F2.jpg

相似文献

1
Slowing Thoracic Aortic Aneurysm Growth with Statins: A Meta-Analysis.他汀类药物延缓胸主动脉瘤生长:一项荟萃分析。
Curr Cardiol Rev. 2025;21(5):112-116. doi: 10.2174/011573403X343512250127075044.
2
Systematic Review of the Growth Rates and Influencing Factors in Thoracic Aortic Aneurysms.胸主动脉瘤生长速度及其影响因素的系统评价
Eur J Vasc Endovasc Surg. 2016 May;51(5):674-81. doi: 10.1016/j.ejvs.2016.01.017. Epub 2016 Mar 2.
3
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.用于预防心脏搭桥手术后急性肾损伤的HMG CoA还原酶抑制剂(他汀类药物)。
Cochrane Database Syst Rev. 2015 Mar 11;2015(3):CD010480. doi: 10.1002/14651858.CD010480.pub2.
4
Bisphosphonates in multiple myeloma: a network meta-analysis.双膦酸盐类药物治疗多发性骨髓瘤:一项网状Meta分析
Cochrane Database Syst Rev. 2012 May 16(5):CD003188. doi: 10.1002/14651858.CD003188.pub3.
5
Bisphosphonates in multiple myeloma: an updated network meta-analysis.双膦酸盐类药物在多发性骨髓瘤中的应用:一项更新的网状Meta分析
Cochrane Database Syst Rev. 2017 Dec 18;12(12):CD003188. doi: 10.1002/14651858.CD003188.pub4.
6
Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.围手术期他汀类药物治疗以改善非心脏血管手术期间及术后的结局。
Cochrane Database Syst Rev. 2013 Jul 3;2013(7):CD009971. doi: 10.1002/14651858.CD009971.pub2.
7
Medical treatment for small abdominal aortic aneurysms.小腹主动脉瘤的医学治疗。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009536. doi: 10.1002/14651858.CD009536.pub2.
8
Endovascular repair of abdominal aortic aneurysm.腹主动脉瘤的血管内修复术。
Cochrane Database Syst Rev. 2014 Jan 23;2014(1):CD004178. doi: 10.1002/14651858.CD004178.pub2.
9
Statins for Smith-Lemli-Opitz syndrome.他汀类药物治疗 Smith-Lemli-Opitz 综合征。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013521. doi: 10.1002/14651858.CD013521.pub2.
10
Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness.系统评价和荟萃分析小的腹主动脉瘤的生长和破裂率:对监测间隔及其成本效益的影响。
Health Technol Assess. 2013 Sep;17(41):1-118. doi: 10.3310/hta17410.

本文引用的文献

1
The ascending aortic aneurysm: When to intervene?升主动脉瘤:何时进行干预?
Int J Cardiol Heart Vasc. 2015 Jan 20;6:91-100. doi: 10.1016/j.ijcha.2015.01.009. eCollection 2015 Mar 1.
2
Statins improve cardiac endothelial function to prevent heart failure with preserved ejection fraction through upregulating circRNA-RBCK1.他汀类药物通过上调 circRNA-RBCK1 改善心脏内皮功能,预防射血分数保留性心力衰竭。
Nat Commun. 2024 Apr 5;15(1):2953. doi: 10.1038/s41467-024-47327-z.
3
Potential Benefits and Risks Associated with the Use of Statins.
使用他汀类药物相关的潜在益处和风险。
Pharmaceutics. 2024 Feb 1;16(2):214. doi: 10.3390/pharmaceutics16020214.
4
The effects of statin therapy on aneurysm size, growth rate, and matrix metalloproteinases-9 levels in patients with aortic aneurysm: a systematic review and meta-analysis.他汀类药物治疗对主动脉瘤患者动脉瘤大小、生长速率及基质金属蛋白酶-9水平的影响:一项系统评价与荟萃分析
Egypt Heart J. 2023 Oct 13;75(1):88. doi: 10.1186/s43044-023-00407-9.
5
Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements-A Narrative Review.降脂药物和补充剂的抗炎作用——一项叙述性综述
Nutrients. 2023 Mar 21;15(6):1517. doi: 10.3390/nu15061517.
6
The mechanism and therapy of aortic aneurysms.主动脉瘤的机制与治疗。
Signal Transduct Target Ther. 2023 Feb 3;8(1):55. doi: 10.1038/s41392-023-01325-7.
7
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2022 ACC/AHA 血管疾病诊断与管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2022 Dec 13;146(24):e334-e482. doi: 10.1161/CIR.0000000000001106. Epub 2022 Nov 2.
8
Effect of statins on abdominal aortic aneurysm.他汀类药物对腹主动脉瘤的影响。
Eur J Pharm Sci. 2022 Nov 1;178:106284. doi: 10.1016/j.ejps.2022.106284. Epub 2022 Aug 26.
9
Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases.他汀类药物通过调节Nrf2和Nrf2/HO-1信号通路在不同疾病中的抗氧化作用
J Clin Med. 2022 Feb 27;11(5):1313. doi: 10.3390/jcm11051313.
10
Vascular Smooth Muscle Cells in Aortic Aneurysm: From Genetics to Mechanisms.主动脉瘤中的血管平滑肌细胞:从遗传学角度到机制。
J Am Heart Assoc. 2021 Dec 21;10(24):e023601. doi: 10.1161/JAHA.121.023601. Epub 2021 Nov 19.